These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4219842)

  • 1. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
    Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
    Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.
    De Bracco MM; Stroud RM; Christian CL
    Clin Exp Immunol; 1972 Jun; 11(2):209-18. PubMed ID: 4625157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement in rheumatoid articular inflammation].
    Boloşiu HD; Duţu A; Duţu D; Duma V; Gligore V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(6):469-74. PubMed ID: 3842
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
    Hedberg H; Laurell AB
    Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS; Glovsky M
    Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitro.
    Burge JJ; Fearon DT; Austen KF
    J Immunol; 1978 May; 120(5):1625-30. PubMed ID: 659867
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.
    Raepple E; Hill HU; Loos M
    Immunochemistry; 1976 Mar; 13(3):251-5. PubMed ID: 1278930
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood and synovial concentrations of an inhibitor of C 1s esterase in rheumatoid arthritis].
    Ambanelli U; Troise W; Fadda G; Nervetti A
    Reumatismo; 1972; 24(4):245-50. PubMed ID: 4681346
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.
    de Ceulaer C; Papazoglou S; Whaley K
    Immunology; 1980 Sep; 41(1):37-43. PubMed ID: 6903558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
    Schultz DR; Loos M; Bub F; Arnold PI
    J Immunol; 1980 Mar; 124(3):1251-7. PubMed ID: 7358983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative immunological studies of the blood serum and synovial fluid in rheumatoid arthritis].
    Lavrova TR; Rodshteĭn OA; Kositskaia LS; Bogdanova MA; Fridman EM
    Vopr Revm; 1980; (2):37-40. PubMed ID: 7405118
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of decrease in complement levels in the synovial fluid during rheumatoid arthritis. 3. Comparison between the quantitative consumption of total complement and its first 2 components (C1 and C2) during antigen-antibody reactions].
    Leroy CJ; Peltier AP
    Pathol Biol (Paris); 1972 Dec; 20(23):993-9. PubMed ID: 4568038
    [No Abstract]   [Full Text] [Related]  

  • 15. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriolytic and bactericidal activity of sera and synovial fluids in rheumatoid arthritis and in osteoarthritis.
    Pruzanski W; Leers WD; Wardlaw AC
    Arthritis Rheum; 1974; 17(3):207-17. PubMed ID: 4207712
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.
    Soter NA; Austen KF; Gigli I
    J Immunol; 1975 Mar; 114(3):928-32. PubMed ID: 1167567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--II. Effect of polyanions on the binding of C2 to EAC4b.
    Loos M; Volanakis JE; Stroud RM
    Immunochemistry; 1976 Mar; 13(3):257-61. PubMed ID: 1278931
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the complement and properdin systems in rheumatoid arthritis.
    Ruddy S; Austen KF
    Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.